What Genetworx does

Genetworx, LLC is a privately held, CLIA-certified and CAP-accredited molecular diagnostic laboratory headquartered at 4060 Innslake Drive in Glen Allen, Virginia. Founded in 2013 as a pharmacogenetics (PGx) testing company under the EffectiveRX brand, it built its initial business around helping clinicians select and dose medications based on patient genetics. During the COVID-19 pandemic the company executed a major operational pivot, scaling from approximately 60 to nearly 700 employees, launching mobile PCR laboratories in Woodbridge, New Jersey and Phoenix, Arizona, and accumulating more than 10 million COVID-19 diagnostic tests performed nationwide.

The company's product portfolio rests on PCR molecular diagnostics and centers on three pillars: (1) COVID-19 and respiratory testing, including PCR, antigen, antibody, at-home self-collection kits (authorized under FDA EUA), and a Flu A-B/COVID/RSV combination test with 96-99% accuracy; (2) pathogen panels for UTI, GI, wound, nail, GYN, and ENT infections with antimicrobial-resistance detection; and (3) the EffectiveRX PGx program, supported by the proprietary PhAESIS interpretation system and PharmD consultations that produce a Medication Action Plan. Operations are enabled by Aura, a proprietary end-to-end software platform for test scheduling, contact tracing, compliance and government reporting, and by the provider portal at orders.genetworx.com.

Genetworx monetizes through a mix of per-test pricing for businesses (e.g., $17.50 per COVID-19 antigen test), Medicare/Medicaid-covered PGx testing at $0 patient out-of-pocket for eligible indications, managed end-to-end testing programs (onsite staffing, sample collection, compliance reporting) for universities, K-12 schools, employers, long-term care operators, and government agencies, plus direct-to-consumer channels via the TestNowandGo drive-up locations and at-home kits. GTM is sales-led enterprise with named accounts including Brandywine Living, Bucknell and Widener Universities, VCU Medical Center, Henrico County, and the Virginia Department of Health. The company holds no disclosed institutional funding rounds and appears to have grown organically through pandemic-driven demand.

Name

Genetworx

Legal name

Genetworx, LLC

Website

https://genetworx.com

Company type

Private

Founded year

2013

Operating status

Operating

Headcount range

1–10 employees

Short description

Genetworx is a CLIA-certified molecular diagnostic laboratory providing PCR-based COVID-19, respiratory, pathogen, and pharmacogenomics testing for healthcare providers, universities, employers, long-term care, and government clients nationwide from Glen Allen, Virginia.

Ownership category

akta.pro rank

Product category

Molecular Diagnostic Laboratory Services

NAICS

Medical Laboratories (621511)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF)

akta.pro secondary industries

Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD), Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

Keywords

• Molecular diagnostic testing
• Pharmacogenomic testing services
• COVID-19 PCR testing
• Pathogen detection panels
• Clinical laboratory services

Headquarters

HQ city

Glen Allen

HQ country

United States

HQ region

North America

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Supply Chain, Infrastructure, Marketing or Sales

Revenue model

1. COVID-19 Diagnostic Testing: PCR and antigen testing services for individuals and organizations. Revenue generated from test kit sales and laboratory testing services. Commercial antigen tests priced at $17.50/ea.
2. Pharmacogenomics Testing: PGx testing services including EffectiveRX Comprehensive Panel and Neuropsychiatric Panel. Medicare Part B, Medicare Advantage and Medicaid covered tests with $0 out-of-pocket cost for eligible patients. Commercial insurance and uninsured patients have varying costs.
3. Managed Testing Programs: End-to-end testing programs for colleges, universities, K-12 schools, corporations, and government. Includes onsite testing setup, staffing, sample collection, and reporting services.
4. At-Home Self-Collection Kits: FDA-authorized COVID-19 at-home self-collection test kits sold directly to individuals. Kits include nasal swab collection materials and prepaid FedEx return mailer.
5. Pathogen Testing Services: Molecular pathogen testing for UTI, GI Health, GYN Health, Wound, Nail, and ENT infections. Identifies specific pathogens and antimicrobial resistance patterns.
6. Antibody Testing: COVID-19 antibody testing services in addition to diagnostic testing.

Pricing tiers

Go-to-market motion3 records

Distribution channels6 records

Marketing channels6 records

Core offering

Genetworx is a national molecular diagnostic laboratory providing PCR-based testing services for COVID-19, pharmacogenomics (PGx), and infectious pathogens (UTI, GI, GYN, wound, nail, ENT). The company serves both organizations (universities, schools, employers, government, healthcare providers, long-term care) through managed testing programs and individual consumers through FDA-authorized at-home self-collection test kits. Supporting the lab operations is the proprietary Aura software platform for test scheduling, reporting, contact tracing, and compliance management.

Product overview

Genetworx is a molecular diagnostic laboratory offering a comprehensive portfolio of PCR-based testing products and services. The core offerings include COVID-19 diagnostic testing (PCR, antigen, and antibody), the Flu A-B/COVID/RSV Combo Test for respiratory illness detection, and an extensive pharmacogenomics (PGx) program under the EffectiveRX brand that analyzes genetic variants to guide medication selection. Supporting services include pathogen panels for gastrointestinal, nail, wound, UTI, GYN, and ENT infections, all using molecular PCR technology with 99% accuracy and 24-48 hour turnaround. The company also provides the proprietary Aura software platform for COVID-19 population management and testing compliance, along with at-home self-collection kits and on-site testing services for businesses, schools, universities, and healthcare organizations.

Differentiator

Problem solved

Functional benefit

Brands

• Aura: Proprietary COVID-19 reporting and security software providing end-to-end digital management and medical data system for population testing management
• EffectiveRX
• TestNowandGo
• GENETWORx

Products and services

• COVID-19 Diagnostic Testing Molecular diagnostic testing for COVID-19 including PCR tests, antigen tests, and self-collection kits with 99% accuracy and results within 24-48 hours. Available to organizations and individual consumers.
• Flu A-B/COVID/RSV Combo Test Combination molecular diagnostic test detecting influenza A and B, RSV, and COVID-19 from a single sample with 98% accuracy for influenza, 99% for COVID-19, and 96% for RSV.
• EffectiveRX Pharmacogenomics (PGx) Testing Pharmacogenetic testing that analyzes genetic variants to help doctors determine optimal medication and dosage for patients based on their DNA, covering genes such as CYP2C9, CYP2C19, CYP2D6, CYP3A4, CYP3A5, F2, F5, MTHFR, and VKORC1. Includes the EffectiveRX Comprehensive Panel and Neuropsychiatric Panel, with results delivered as a Medication Action Plan (MAP).
• GI Pathogens Panel PCR gastrointestinal pathogen testing detecting 14 pathogens including Adenovirus 40/41, Campylobacter, C. difficile, ETEC, STEC, Salmonella, Shigella, Norovirus, Rotavirus, Giardia, Cryptosporidium, H. pylori, and Vibrio cholerae with 99% accuracy in 48 hours.
• Nail Pathogen Panel PCR nail diagnostics testing detecting 30 pathogens and 18 antibiotic resistances including bacteria (MRSA, MSSA, Streptococci), fungi (Candida species, Trichophyton), and antibiotic resistance markers.
• Wound Pathogen Panel PCR wound infection diagnostics detecting more than 30 wound pathogens with 99% accuracy within 24-48 hours.
• Urinary Tract Infection (UTI) Testing Molecular pathogen testing for UTI detection and antimicrobial resistance identification.
• GYN Pathogen Testing Molecular diagnostic testing for gynecological pathogen detection.
• ENT Pathogen Panel Molecular diagnostic testing for ear, nose, and throat pathogens.
• Aura Software Platform Proprietary COVID-19 reporting and population management software providing end-to-end digital test management, scheduling, symptom tracking, contact tracing, dashboards, compliance reporting, and QR-code based entry screening for organizations.
• COVID-19 At-Home Self-Collection Kits FDA-authorized nasal swab self-collection test kits for home use, allowing patients to collect samples and mail them to the lab for PCR testing with results within 24-48 hours. Available for individual consumer purchase.
• On-Site Testing Services Managed COVID-19 testing services for organizations including self-service model (providing testing packages) and full-service model (end-to-end collection to results management).
• COVID-19 Antibody Testing COVID-19 antibody testing to detect prior infection and immune response.
• Pooled Testing Program for K-12 Schools High-volume COVID-19 pooled testing program for K-12 schools with capacity for up to 60 million tests per month, enabling safe return to in-person learning.
• COVID-19 Saliva PCR Test Molecular saliva test for COVID-19 detection with greater than 98% accuracy and results delivered within 48 hours, providing a non-invasive alternative to nasopharyngeal collection.
• Mobile PCR Laboratory Services Fully equipped state-of-the-art mobile PCR laboratories deployed on East Coast (Woodbridge, New Jersey) and West Coast (Phoenix, Arizona), enabling accelerated 8-12 hour turnaround times for COVID-19 PCR testing.

Quantifiable outcome

• 99% accurate results for pathogen testing within 24-48 hours of sample receipt
• +7 more outcomes

Named customers14 records

Segments9 records

Ideal customer profiles7 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Partnerships

16 partnerships are on record, tiered major, core and minor.

• Virginia Department of HealthmajorStrategic or Co-development Partner · 1 April 2021Partnership with Virginia Department of Health for COVID-19 testing programs in public schools. Virginia launched a pilot program to provide rapid antigen tests to schools across the state.
• Henrico County, VirginiacoreStrategic or Co-development Partner · 11 February 2021GENETWORx partnered with Henrico County, Virginia to build an extensive laboratory and managed testing platform that has performed millions of accurate COVID-19 diagnostic tests. This partnership enabled the company to scale significantly during the pandemic.
• Widener UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester as part of comprehensive mandatory testing for students and staff.
• Gwynedd Mercy UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Southern Illinois UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Loyola University MarylandmajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Alvernia UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Holy Family UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Haverford CollegemajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Washington & Lee UniversitymajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• Lewis and Clark State CollegemajorStrategic or Co-development Partner · 1 January 2021On-campus COVID-19 managed testing program during Spring 2021 semester.
• TestNowandGomajorChannel Partner/ Reseller/ Distributor · 1 January 2021Drive-up COVID-19 testing locations in partnership offering rapid point of care antigen and molecular in-person testing. Locations in New York City, Virginia, Phoenix, Boston, and Philadelphia.
• Virginia Commonwealth University Medical CentercoreStrategic or Co-development Partner · 1 January 2021Partnership for pharmacogenetics, infectious disease, cancer genomics, pathogen, and toxicology services. Early diagnostics laboratory partner.
• Bucknell UniversitycoreStrategic or Co-development Partner · 25 July 2020Bucknell partnered with TCA/GENETWORx to deliver two free COVID test kits to each student and implemented mandatory testing requirements for campus return. The partnership enabled Bucknell to complete an on-campus academic year during the pandemic.
• Brandywine LivingcoreStrategic or Co-development Partner · 1 March 2020COVID-19 testing partnership for assisted-living communities with over 3,000 residents in 31 communities across seven states. Brandywine turned to GENETWORx when scrambling to find laboratories that could conduct tests for residents and staff.
• Recovery Centers of AmericaminorStrategic or Co-development PartnerAffiliated covered entities under HIPAA. Recovery Centers of America affiliated with GENETWORx for healthcare operations including billing and patient care coordination.

Scale indicators18 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Quest Diagnostics: One of the largest U.S. clinical laboratory networks offering PCR-based infectious disease, molecular, and pharmacogenomic testing. Overlaps directly with Genetworx's COVID PCR, pathogen panels, and PGx offerings, but at national scale with a far broader test menu and payer footprint.
• Laboratory Corporation of America (Labcorp): National clinical lab providing PCR molecular diagnostics, infectious disease testing, and specialty PGx tests. Competes for the same enterprise employer, healthcare-provider, and university accounts that Genetworx serves, with substantially larger infrastructure.
• Mayo Clinic Laboratories: Reference laboratory within a major academic medical center providing esoteric molecular, infectious-disease, and pharmacogenomic testing. Comparable high-complexity menu with clinical-decision-support depth relevant to VCU-partnered PGx work.
• Sonic Healthcare USA: Major clinical laboratory operator in the U.S. through subsidiaries (e.g., Sunrise Medical Labs, American Esoteric Laboratories) delivering molecular, infectious-disease and pharmacogenomics testing. Competes for enterprise and healthcare-provider clients with national reach similar to Genetworx's positioning.

Direct peers

• BioReference Laboratories: Specialty clinical laboratory with strength in molecular infectious-disease and pharmacogenomic testing, including high-volume COVID PCR and population-management deployments for schools and employers. Closest mid-sized direct competitor to Genetworx on product mix and customer segments.
• ARUP Laboratories: Nonprofit academic clinical laboratory offering high-complexity molecular diagnostics, infectious-disease PCR panels, and pharmacogenomic testing. Comparable in test depth and CAP-accredited clinical quality, with similar focus on hospital/health-system clients.
• Myriad Genetics: Specialty molecular diagnostics company with proprietary tests spanning pharmacogenomics, infectious disease, and other genetic testing. Comparable focus on monetizing genomic information for clinical decision-making, including PGx offerings like GeneSight.
• Eurofins Viracor BioPharma: Specialty infectious-disease and immunology reference laboratory within Eurofins offering high-complexity molecular pathogen testing with rapid turnaround. Directly comparable to Genetworx in serving transplant, immunocompromised, and complex patient populations.

Emerging players

• Exact Sciences: Diagnostics company expanding beyond Cologuard into molecular infectious disease and other PCR-based testing. Overlaps in clinical-decision-support orientation and in scaling a single proprietary assay platform across multiple indications.
• Infinity BiologiX: Clinical and research biobanking and molecular testing lab that scaled up COVID PCR capacity during the pandemic and now serves academic, government, and population-genomics clients. Comparable in scale-down trajectory, molecular focus, and university/government contract orientation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/genetworxlab
• LinkedInlinkedin.com/company/genetworx
• Xx.com/genetworx

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetworx